Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV

Impaired antibody response to COVID-19 vaccination in advanced HIV infection

(2022) Nolan Hassold et al.   AIDS

Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection

(2021) Catherine J. Reynolds et al.   Science Immunology

Safety and antibody response to the first dose of SARS-CoV-2 messenger RNA vaccine in persons with HIV

(2021) Jake A. Ruddy et al.   AIDS

The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV)

(2021) Bezawit A Woldemeskel et al.   CLINICAL INFECTIOUS DISEASES

Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort

(2021) Juan Berenguer et al.   CLINICAL MICROBIOLOGY AND INFECTION

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1

(2021) Itzchak Levy et al.   CLINICAL MICROBIOLOGY AND INFECTION

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial

(2021) John Frater et al.   Lancet HIV

Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV

(2021) Emma Touizer et al.   Lancet HIV

Humoral response to two doses of BNT162b2 vaccination in people with HIV

(2021) Line Dam Heftdal et al.   JOURNAL OF INTERNAL MEDICINE

Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis

(2021) Victoria Rotshild et al.   Scientific Reports

Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?

(2021) Gregory Milne et al.   Lancet Respiratory Medicine

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial

(2021) Peter Bergman et al.   EBioMedicine

Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody

(2020) Marie Tré-Hardy et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Outcomes of COVID-19 related hospitalization among people with HIV in the ISARIC WHO Clinical Characterization Protocol (UK): a prospective observational study

(2020) Anna Maria Geretti et al.   CLINICAL INFECTIOUS DISEASES

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

(2020) Merryn Voysey et al.   LANCET

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term Immune Responses to Vaccination in HIV-Infected Patients: A Systematic Review and Meta-Analysis

(2014) S. Kerneis et al.   CLINICAL INFECTIOUS DISEASES

HIV-associated chronic immune activation

(2013) Mirko Paiardini et al.   IMMUNOLOGICAL REVIEWS

Correlates of Protection Induced by Vaccination

(2010) S. A. Plotkin   Clinical and Vaccine Immunology